|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:LRP5-MADD (FusionGDB2 ID:49555) |
Fusion Gene Summary for LRP5-MADD |
Fusion gene summary |
Fusion gene information | Fusion gene name: LRP5-MADD | Fusion gene ID: 49555 | Hgene | Tgene | Gene symbol | LRP5 | MADD | Gene ID | 4041 | 8567 |
Gene name | LDL receptor related protein 5 | MAP kinase activating death domain | |
Synonyms | BMND1|EVR1|EVR4|HBM|LR3|LRP-5|LRP-7|LRP7|OPPG|OPS|OPTA1|PCLD4|VBCH2 | DENN|IG20|RAB3GEP | |
Cytomap | 11q13.2 | 11p11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | low-density lipoprotein receptor-related protein 5low density lipoprotein receptor-related protein 5low density lipoprotein receptor-related protein 7 | MAP kinase-activating death domain proteinRab3 GDP/GTP exchange factordifferentially expressed in normal and neoplastic cellsinsulinoma glucagonoma clone 20 | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | O75197 | Q8WXG6 | |
Ensembl transtripts involved in fusion gene | ENST00000294304, ENST00000529481, | ENST00000342922, ENST00000402799, ENST00000311027, ENST00000406482, ENST00000407859, ENST00000349238, ENST00000395344, ENST00000395336, ENST00000402192, ENST00000405573, ENST00000489415, | |
Fusion gene scores | * DoF score | 36 X 25 X 12=10800 | 5 X 6 X 3=90 |
# samples | 41 | 6 | |
** MAII score | log2(41/10800*10)=-4.71926359243275 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/90*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LRP5 [Title/Abstract] AND MADD [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | LRP5(68208849)-MADD(47345222), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LRP5 | GO:0008284 | positive regulation of cell proliferation | 9790987 |
Hgene | LRP5 | GO:0045840 | positive regulation of mitotic nuclear division | 9790987 |
Hgene | LRP5 | GO:0045893 | positive regulation of transcription, DNA-templated | 15035989|17955262 |
Hgene | LRP5 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 12857724 |
Hgene | LRP5 | GO:0060070 | canonical Wnt signaling pathway | 11029007|12121999|12857724|15908424|24706814|25920554 |
Tgene | MADD | GO:0032483 | regulation of Rab protein signal transduction | 20937701 |
Tgene | MADD | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 11577081 |
Fusion gene breakpoints across LRP5 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across MADD (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-LL-A6FQ-01A | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
ChimerDB4 | BRCA | TCGA-LL-A6FQ-01A | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
Top |
Fusion Gene ORF analysis for LRP5-MADD |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000294304 | ENST00000342922 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000402799 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000311027 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000406482 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000407859 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000349238 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000395344 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000395336 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000402192 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000294304 | ENST00000405573 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-intron | ENST00000294304 | ENST00000489415 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000342922 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000402799 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000311027 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000406482 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000407859 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000349238 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000395344 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000395336 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000402192 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-3CDS | ENST00000529481 | ENST00000405573 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
intron-intron | ENST00000529481 | ENST00000489415 | LRP5 | chr11 | 68208849 | + | MADD | chr11 | 47345222 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for LRP5-MADD |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for LRP5-MADD |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
LRP5 | MADD |
FUNCTION: Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins (PubMed:11336703, PubMed:11448771, PubMed:15778503, PubMed:11719191, PubMed:15908424, PubMed:16252235). Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration (PubMed:11336703, PubMed:11719191). In particular, may play an important role in the development of the posterior patterning of the epiblast during gastrulation (By similarity). During bone development, regulates osteoblast proliferation and differentiation thus determining bone mass (PubMed:11719191). Mechanistically, the formation of the signaling complex between Wnt ligand, frizzled receptor and LRP5 coreceptor promotes the recruitment of AXIN1 to LRP5, stabilizing beta-catenin/CTNNB1 and activating TCF/LEF-mediated transcriptional programs (PubMed:11336703, PubMed:25920554, PubMed:24706814, PubMed:14731402). Acts as a coreceptor for non-Wnt proteins, such as norrin/NDP. Binding of norrin/NDP to frizzled 4/FZD4-LRP5 receptor complex triggers beta-catenin/CTNNB1-dependent signaling known to be required for retinal vascular development (PubMed:27228167, PubMed:16252235). Plays a role in controlling postnatal vascular regression in retina via macrophage-induced endothelial cell apoptosis (By similarity). {ECO:0000250|UniProtKB:Q91VN0, ECO:0000269|PubMed:11336703, ECO:0000269|PubMed:11448771, ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:14731402, ECO:0000269|PubMed:15778503, ECO:0000269|PubMed:15908424, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:24706814, ECO:0000269|PubMed:25920554, ECO:0000269|PubMed:27228167}. | FUNCTION: Plays a significant role in regulating cell proliferation, survival and death through alternative mRNA splicing. Isoform 5 shows increased cell proliferation and isoform 2 shows decreased. Converts GDP-bound inactive form of RAB3A, RAB3C and RAB3D to the GTP-bound active forms. Component of the TNFRSF1A signaling complex: MADD links TNFRSF1A with MAP kinase activation. Plays an important regulatory role in physiological cell death (TNF-alpha-induced, caspase-mediated apoptosis); isoform 1 is susceptible to inducing apoptosis, isoform 5 is resistant and isoform 3 and isoform 4 have no effect. {ECO:0000269|PubMed:11577081, ECO:0000269|PubMed:14716293, ECO:0000269|PubMed:14735464, ECO:0000269|PubMed:15007167, ECO:0000269|PubMed:20937701, ECO:0000269|PubMed:9115275}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for LRP5-MADD |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for LRP5-MADD |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for LRP5-MADD |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for LRP5-MADD |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | LRP5 | C1866176 | EXUDATIVE VITREORETINOPATHY 4 (disorder) | 10 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | LRP5 | C0432252 | Osteoporosis with pseudoglioma | 8 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | LRP5 | C1866079 | BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1 | 6 | GENOMICS_ENGLAND;UNIPROT |
Hgene | LRP5 | C1843330 | OSTEOPETROSIS, AUTOSOMAL DOMINANT 1 | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | LRP5 | C4693479 | POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS | 3 | GENOMICS_ENGLAND;UNIPROT |
Hgene | LRP5 | C0432273 | Worth disease | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | LRP5 | C1843323 | Van Buchem disease type 2 | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | LRP5 | C0015397 | Disorder of eye | 1 | GENOMICS_ENGLAND |
Hgene | LRP5 | C0035344 | Retinopathy of Prematurity | 1 | ORPHANET |
Hgene | LRP5 | C0151879 | Shortened QT interval | 1 | GENOMICS_ENGLAND |
Hgene | LRP5 | C0158683 | Polycystic liver disease | 1 | ORPHANET |
Hgene | LRP5 | C0242852 | Proliferative vitreoretinopathy | 1 | CTD_human |
Hgene | LRP5 | C0339539 | Familial Exudative Vitreoretinopathy | 1 | CTD_human |
Hgene | LRP5 | C0432272 | Van Buchem disease | 1 | ORPHANET |
Hgene | LRP5 | C1851402 | Exudative vitreoretinopathy 1 | 1 | CTD_human;UNIPROT |